Explore 3 Stock Ideas & Industry Insights Download Free Report
Polar Capital Global Healthcare Trust (LSE:PCGH), the FTSE 250-listed specialistInvestmenttrust focused on healthcare companies worldwide, enters the closing months of its financial year against an unusually complex backdrop for its sector. Healthcare has lagged the broader stock market for much of the period since …
Oxford Nanopore Technologies (LSE:ONT) has spent much of 2026 trying to rebuild credibility with investors. The FTSE 250 gene sequencing specialist reported half-year results showing revenue of £116.7 million for the six months to 30 June, up 11%, or 12% at constant currency. Losses …
• New shares were issued through a placing and subscription at 68p.
Genus (LSE:GNS), the porcine and bovine genetics specialist, has spent the past month putting its strengthenedBalance Sheetto work. Preliminary results for the year to 30 June 2026, published on 10 September, were accompanied by the launch of a £60m share buyback programme for the …
Hikma Pharmaceuticals (LSE:HIK) has filled one of the most closely watched gaps in its senior team. On 24 September the generic and branded medicines group announced that Rebecca Hall will join as chief financial officer and an executive director in the first quarter of …
• Faron has updated the composition of its shareholders’ nomination board.
• Financing materials have been published in connection with the recommended cashAcquisitionof Advanced Medical Solutions.
The momentum has been striking. Over a two-week period, the shares moved from about 173p to 182p, then jumped to 199.4p and 217.6p in successive sessions at the end of September, touching an intraday high of 218.4p before consolidating near 214p. The latest gain …
• The 15-month study aims to recruit 500 participants with memory complaints or early cognitive-decline symptoms.
• The patent covers prevention of cancer immunotherapy-associated cytokine release syndrome.
We use some essential cookies to make this site work. We also set analytics and marketing cookies, described below, to understand how you use the site and to measure our advertising. For more detailed information, see our Cookie Policy, Privacy Policy and Terms and Conditions.
These cookies are necessary for core functionality, such as security, your shopping cart, remembering your cookie choice, and your progress through a report or free-trial request you started. They always need to be on.
We use analytics cookies to understand how visitors use the site — the pages visited, time spent, and where visitors came from.
These help us measure how effective our advertising is, such as recording actions you take after clicking one of our ads. If you don't enable this, you may still see our ads, but they won't be measured this way.
Please wait processing your request...
You are not subscribed for this report, Want to See?
One of our sales representative will contact you soon!
Welcome to Kalkine!
Download Free Report
Hi! How can we help you today?
Loading…